
|Articles|January 27, 2021
Supplements and Featured Publications
- Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis
Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis
Advertisement
The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Guideline-Directed Medical Therapies in Heart Failure
2
Responsible Use of Energy-Based Treatments on Skin of Color: Eliot F. Battle, MD
3
Collaboration in Heart Failure Treatment
4
Coordinating Medications for Women With Arrhythmia: Lindsey Valenzuela, PharmD
5